ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
17517.2 PFLS-LS
Project title
Anti-cancer efficacy and mode of action dissection of a novel first-in class inhibitor of the Notch pathway: MIP: Cellestia Biotech SA

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Professor
Freddy Radtke
EPFL
SV ISREC UPRAD
Life Science Faculty
Station 19
CH-1015 Lausanne
+41 21 693 07 72
freddy.radtke@epfl.ch

Implementation Partner

Doktor
Rajwinder Lehal
Cellestia Biotech AG
CHE-162.364.457
Hochbergerstr. 60C
CH-4057 Basel
raj.lehal@cellestia.com